These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22536647)

  • 41. Extemporaneous compounding activities and the associated informational needs of pharmacists.
    Crawford SY; Dombrowski SR
    Am J Hosp Pharm; 1991 Jun; 48(6):1205-10. PubMed ID: 1858798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, Scope and Quality of Extemporaneous Medications in Selected Healthcare Facilities and Implications for Pharmacy Practice.
    Allotey-Babington GL; Akwo Kretchy I; Atiapa Asiedu E; Kelly Amuakwa M; Akwele Seaneke O; Ankrah D; Kwadwo Somuah A; Dei Owusu-Nyamekye A; Owusu-Ansah S; Kwame Effah P; Debrah J; Acheampomaa Nai E; Owusu E; Lamptey W; Gyekye IJA; Nettey H
    Innov Pharm; 2024; 15(1):. PubMed ID: 38779112
    [No Abstract]   [Full Text] [Related]  

  • 43. [Over-the-counter drug sales in pharmacies].
    Macesková B
    Ceska Slov Farm; 1996 Sep; 45(5):231-6. PubMed ID: 9011309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prescription and structure of formulation of medicinal preparations in a pharmacy I].
    Kolár J; Svejdová J
    Ceska Slov Farm; 2004 Nov; 53(6):319-22. PubMed ID: 15631000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Outlook on the European and Italian Rules to Guarantee Magistral Formulas.
    Selmin F; Casiraghi A; Musazzi UM; Fortini M; Minghetti P
    Int J Pharm Compd; 2019; 23(1):6-12. PubMed ID: 30668530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compounded medication for patients with rare diseases.
    Dooms M; Carvalho M
    Orphanet J Rare Dis; 2018 Jan; 13(1):1. PubMed ID: 29301541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Standard prescriptions for the formulation of medicinal preparations in pharmacies V. The collection Dermatologische Magistralrezepturen der Schweiz].
    Subert J; Kolár J
    Ceska Slov Farm; 2012 Aug; 61(4):159-62. PubMed ID: 23251957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmaceutical chemistry in a pharmacy practice].
    Hankó B; Takácsné NK
    Acta Pharm Hung; 2001 Oct; 71(3):270-9. PubMed ID: 11961893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prescription and structure of formulation of medicinal preparations in a pharmacy. II].
    Kolár J; Svejdová J
    Ceska Slov Farm; 2005 Jan; 54(1):29-33. PubMed ID: 15751792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaceutical prerequisites for a multi-target therapy.
    Kroll U; Cordes C
    Phytomedicine; 2006; 13 Suppl 5():12-9. PubMed ID: 16857355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the content of the National part of the Czech Pharmacopoeia 2017.
    Šubert J; Kolář J
    Ceska Slov Farm; 2018; 67(2):81-84. PubMed ID: 30189737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [View of pharmacists on pharmaceutical care in the Czech Republic].
    Macesková B; Hobzová H
    Ceska Slov Farm; 1999 Jul; 48(4):156-62. PubMed ID: 10566237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacies during the transformation of health care. IV. Sociologic study of pharmacy service].
    Springer V; Karnisová A; Majtás J
    Ceska Slov Farm; 1997 Aug; 46(4):151-6. PubMed ID: 9377060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
    Glass BD; Haywood A
    J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a standardized intranet database of formulation records for nonsterile compounding, part 1.
    Evans A; Haile M; Anderson K
    Int J Pharm Compd; 2010; 14(5):401-5. PubMed ID: 23965584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Considerations before choosing (extemporaneously) compounded products.
    Krochmal L
    Dermatol Ther; 2009; 22(3):225-8. PubMed ID: 19453346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid dosage forms extemporaneously prepared from commercially available products - considering new evidence on stability.
    Haywood A; Glass BD
    J Pharm Pharm Sci; 2013; 16(3):441-55. PubMed ID: 24021292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-Hospital Production of Medicines: Preparing for Disruption.
    Kalkman S; Arentshorst M; Hoekman J; Boon W; Uijtendaal E; van Thiel G; Moors E
    Trends Biotechnol; 2020 Oct; 38(10):1045-1047. PubMed ID: 31679825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Audits of radiopharmaceutical formulations.
    Castronovo FP
    Am J Hosp Pharm; 1992 Mar; 49(3):584-90. PubMed ID: 1598931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.